Connor, Clark & Lunn Investment Management (CC&L)’s ResMed RMD Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$32.1M Buy
124,245
+57,139
+85% +$14.7M 0.11% 159
2025
Q1
$15M Buy
67,106
+5,166
+8% +$1.16M 0.07% 243
2024
Q4
$14.2M Buy
61,940
+38,346
+163% +$8.77M 0.06% 238
2024
Q3
$5.76M Buy
23,594
+19,184
+435% +$4.68M 0.03% 402
2024
Q2
$844K Buy
4,410
+3,199
+264% +$612K ﹤0.01% 890
2024
Q1
$240K Sell
1,211
-95,507
-99% -$18.9M ﹤0.01% 1347
2023
Q4
$16.6M Sell
96,718
-126,292
-57% -$21.7M 0.08% 203
2023
Q3
$33M Buy
223,010
+219,402
+6,081% +$32.4M 0.17% 113
2023
Q2
$788K Buy
+3,608
New +$788K ﹤0.01% 865
2022
Q3
Sell
-1,023
Closed -$214K 1229
2022
Q2
$214K Sell
1,023
-662
-39% -$138K ﹤0.01% 922
2022
Q1
$409K Buy
+1,685
New +$409K ﹤0.01% 818
2021
Q3
Sell
-14,030
Closed -$3.46M 1197
2021
Q2
$3.46M Sell
14,030
-8,888
-39% -$2.19M 0.02% 433
2021
Q1
$4.45M Buy
22,918
+4,419
+24% +$857K 0.02% 384
2020
Q4
$3.93M Buy
18,499
+3,835
+26% +$815K 0.02% 388
2020
Q3
$2.51M Buy
+14,664
New +$2.51M 0.02% 434
2020
Q2
Sell
-14,593
Closed -$2.15M 1156
2020
Q1
$2.15M Buy
+14,593
New +$2.15M 0.02% 402
2018
Q3
Sell
-10,625
Closed -$1.1M 1086
2018
Q2
$1.1M Buy
+10,625
New +$1.1M 0.01% 592